2,126 results match your criteria: "Bnai Zion Medical Center[Affiliation]"
Support Care Cancer
December 2024
Ruth and Bruch Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Objective: The present conflict in Israel has led to a surge in cases of acute stress disorder (ASD). The study examined a training program for integrative medicine (IM) providers working in supportive and palliative care settings, teaching clinical skills for treating ASD.
Methods: A 10-h online training program, designed by supportive care trained IM and mental health professionals was attended by a group of 32 IM providers.
Harefuah
December 2024
Eosinophilic Gastrointestinal Disease Clinic, Gastroenterology and Hepatology Unit in collaboration with Immunology and Allergy Unit, Bnai Zion Medical Center, Haifa.
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus, which is mediated by Th2 cells that could start at any age, from early childhood to adulthood. The pathogenesis of the disease is not fully understood, but apparently it consists of a combined interaction between hereditary and environmental factors. Over the years, EoE has become an increasingly diagnosed disease in the context of esophageal symptoms.
View Article and Find Full Text PDFDiagnostics (Basel)
November 2024
Endocrinology Unit, Bnai Zion Medical Center, 47 Eliyahu Golomb Boulevard, Haifa 31048, Israel.
: To assess success rates and cost-effectiveness of adrenal venous sampling (AVS) after implementing point-of-care rapid cortisol (RC) testing conducted using a europium nanoparticle-based fluoro-immunoassay in patients with primary hyperaldosteronism. : A retrospective review of AVS procedures was conducted at our medical center between January 2016 and June 2024. The primary objective was to compare the success rates of AVS before and after the implementation of the RC testing.
View Article and Find Full Text PDFPLoS One
December 2024
Oncology Unit, Bnai Zion Medical Center, Haifa, Israel.
Musculoskeletal Care
December 2024
Rheumatology Unit, Bnai Zion Medical Center, Haifa, Israel.
Objectives: Direct hand function is not commonly evaluated in patients with rheumatoid arthritis (RA). The Functional Dexterity Test (FDT) assesses a patient's ability to use the hand for daily tasks and is an accepted quantitative assessment tool in occupational medicine. This pilot study aimed to examine the correlations of FDT-measured hand performance with disease activity status in a cohort of RA patients.
View Article and Find Full Text PDFCochlear Implants Int
July 2024
Department of Otolaryngology, Hacettepe University Medical Faculty, Ankara, Turkey.
Ann Rheum Dis
November 2024
Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Tel Aviv, Israel.
Invest Ophthalmol Vis Sci
November 2024
The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Purpose: To explore the effect of cobalt toxicity on vision.
Methods: A total of 103 wild-type (WT) mice were injected with cobalt chloride by two routes in different concentrations: single intravenous (IV) high or low doses (total, n = 43); or daily repeated intraperitoneal (IP) high (three days) or low (28 days, 56 days) dose, and low-dose cobalt with added minocycline (56 days) (total, n = 60); 10 WT mice served as a control group. An additional group of 17 immunodeficient NOD scid gamma (NSG) mice were injected IV or IP with cobalt, and 10 NSG mice served as control.
Biomolecules
November 2024
Department of Morphological Sciences, Adelson School of Medicine, Ariel University, Ariel 40700, Israel.
Children (Basel)
October 2024
Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3104802, Israel.
(1) Background: Participation in daily activities is critical for a child's health, development and wellbeing and is considered a main outcome measure of intervention efficiency. Atopic diseases affect children's daily life and routines but the knowledge about impacts on participation is limited. (2) Objectives: a.
View Article and Find Full Text PDFPaediatr Drugs
November 2024
Department of Neonatology, Shamir Medical Center, Zerifin, Israel.
Introduction: Less invasive surfactant administration (LISA) involves delivering surfactant to a spontaneously breathing infant by passing a thin catheter through the vocal cords and has become the preferred method for surfactant delivery. However, the role of pre-LISA sedation remains unclear.
Objective: The aim of this study was to describe the use of dexmedetomidine for LISA in preterm and early-term infants.
Reprod Biomed Online
August 2024
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Bnai Zion Medical Center, Haifa, Israel; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
The study aimed to investigate nutrition-related health behaviors among nursing and medical students compared to healthcare workers (HCWs), including nurses and physicians. A cross-sectional survey was conducted between May and November 2022, using the I-MEDAS and lifestyle-related behavior questionnaires. The participants included nursing and medical students, nurses, and physicians, with a total of 384 participants: 16.
View Article and Find Full Text PDFHarefuah
November 2024
Department of Otolaryngology - Head and Neck Surgery, Rambam Health Care Campus, Haifa, Israel, The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Autoimmun Rev
December 2024
Internal Medicine Unit (04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Centre de Référence des Maladies auto-immunes systémiques Rares d'Ile-de-France, AP-HP, St-Louis Hospital, France; Paris-Cité University, IRSL, Recherche clinique appliquée à l'hématologie, URP 3518, F-75010 Paris, France; Department of Medicine, McGill University, Montreal, QC, Canada. Electronic address:
Systemic Lupus Erythematosus (SLE) is a rare, heterogeneous, potentially life-threatening autoimmune disease. Presence of kidney or other major organ (brain, heart or lung) involvement are predictors of poor outcome and in a subset of patients resistant to 1st or 2nd line conventional treatment. The 10-year mortality remains around 10-15 %.
View Article and Find Full Text PDFJ Clin Med
October 2024
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 35254, Israel.
J Clin Med
October 2024
Department of Neonatology, Rambam Health Care Campus, Haifa 3525408, Israel.
: To assess whether continuous non-invasive pCO monitoring by transcutaneous pCO monitor (TCpCO) among extremely low birth weight (ELBW) premature infants, during the first week of life, will decrease the rate of high-grade intraventricular hemorrhage (IVH) or periventricular leukomalacia (PVL) or the combined outcome of IVH/PVL and death. : This was a prospective, observational, multicenter study. Due to ethical constraints, allocation was based on TCpCO monitor availability.
View Article and Find Full Text PDFPsychooncology
November 2024
Department of Family Medicine, Ruth and Bruch Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Study Objective: The study examined a training program for integrative medicine (IM) providers, teaching clinical skills for treating acute stress disorder (ASD).
Methods: A 10-h online training program, designed by IM and mental health professionals, was attended by a group of 32 IM providers working in supportive and palliative oncology care. Pre- and post-course questionnaires assessed self-perceived levels of IM and mental health ASD-related skills (from 1, very low; to 7, very high).
Cells
October 2024
The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
Cobalt toxicity is difficult to detect and therefore often underdiagnosed. The aim of this study was to explore the pathophysiology of cobalt-induced oxidative stress in the brain and its impact on structure and function. Thirty-five wild-type C57B16 mice received intraperitoneal cobalt chloride injections: a single high dose with evaluations at 24, 48, and 72 h ( = 5, each) or daily low doses for 28 ( = 5) or 56 days ( = 15).
View Article and Find Full Text PDFRheumatology (Oxford)
November 2024
Rheumatology Unit, Bnai Zion Medical Center, Faculty of Medicine, Technion Israel institute of technology, Haifa, Israel.
Introduction: Systemic sclerosis is a complex disease that affects various target organs, making it difficult to assess response and determine remission or relapse. A baseline Neutrophil-to-Lymphocyte Ratio (NLR) >2.95 is associated with severe progressive skin and lung disease and decreased 5-year survival in systemic sclerosis (SSc).
View Article and Find Full Text PDFJ Oral Maxillofac Surg
October 2024
Department of Oral and Maxillofacial Surgery, The Baruch Padeh "Tzafon" Medical Center, Poriya, Israel; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Background: Antibiotic overuse is a growing concern in health care. For pediatric odontogenic infections, the necessity of postoperative antibiotics lacks clear, evidence-based guidelines.
Purpose: The purpose of this study was to compare treatment outcomes between pediatric patients hospitalized with vestibular space odontogenic infections who received postoperative antibiotics and those who did not.
Int J Gynaecol Obstet
October 2024
Department of Obstetrics and Gynecology, Bnai-Zion Medical Center, Technion - Israel Institute of Technology, Haifa, Israel.
Ear Hear
October 2024
Department of Communication Sciences and Disorders, Faculty of Social Welfare and Health Studies, University of Haifa, Haifa, Israel.
Eur J Haematol
October 2024
School of Medicine, Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Objectives: Asciminib, a novel allosteric BCR::ABL1 inhibitor, targets the ABL1 myristoyl pocket to potentially reduce toxicity and enhance efficacy. It is approved for Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia (CML-CP) in patients with resistance or intolerance to two or more tyrosine kinase inhibitors (TKIs) or those with the T315I mutation.
Methods: This retrospective analysis evaluated patients with CML treated with asciminib under a managed-access program across eight Israeli centers from July 2019 to August 2022.